technetium-tc-99m-disofenin and Diabetes-Mellitus

technetium-tc-99m-disofenin has been researched along with Diabetes-Mellitus* in 1 studies

Other Studies

1 other study(ies) available for technetium-tc-99m-disofenin and Diabetes-Mellitus

ArticleYear
Gallbladder function in diabetic patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1986, Volume: 27, Issue:3

    Gallbladder emptying and filling was studied in eight diabetic and six normal control patients. None of the patients had gallstones. Cholescintigraphy was performed using [99mTc]disofenin, and gallbladder emptying was studied using a 45-min i.v. infusion of the octapeptide of cholecystokinin (OP-CCK) 20 ng/kg X hr. The peak filling rate was greater in diabetic than in normal subjects; however, emptying of the gallbladder in response to OP-CCK was significantly less in the diabetic subjects (51.6 +/- 10.4% compared with 77.2 +/- 4.9%). When the diabetic group was subdivided into obese and nonobese diabetics, the obese diabetics had a much lower percentage of emptying than the nonobese diabetics (30.0 +/- 10.4% compared with 73.1 +/- 9.3%). These findings suggest that obese diabetics may have impaired emptying of the gallbladder even in the absence of gallstones. The more rapid rate of gallbladder filling in obesity may indicate hypotonicity of the gallbladder. The combination of these abnormalities may predispose the obese diabetic to the development of gallstones.

    Topics: Adult; Aged; Diabetes Mellitus; Gallbladder; Humans; Imino Acids; Male; Middle Aged; Obesity; Radionuclide Imaging; Risk; Sincalide; Technetium; Technetium Tc 99m Disofenin; Time Factors

1986